Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.
This product will be launched through Granules Consumer Health (GCH) division
PEEK brings a new quality to dental care for patients
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Suven Life Sciences completed enrollment of patients to the phase-2, PoC clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada
Subscribe To Our Newsletter & Stay Updated
